Development of an In Vitro assay for detection of drug-induced resuscitation-promoting-factor-dependent mycobacteria

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 10, 2016, Pages 6227-6233

  Loraine, Jessica ^a,b   Pu, Feifei ^a,c   Turapov, Obolbek ^a   Mukamolova, Galina V ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c Diagnostic Division   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ETHAMBUTOL; ISONIAZID; MEROPENEM; RESUSCITATION PROMOTING FACTOR; RIFAMPICIN; RNA 16S; STREPTOMYCIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CULTURE MEDIUM; CYTOKINE; RESUSCITATION-PROMOTING FACTOR, BACTERIA;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM DETECTION; CONTROLLED STUDY; DRUG EXPOSURE; GENE OVEREXPRESSION; IN VITRO STUDY; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RPFA GENE; RPFB GENE; RPFC GENE; RPFE GENE; SUPERNATANT; TUBERCULOSIS; CULTURE MEDIUM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; PROCEDURES; REPRODUCIBILITY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; CYTOKINES; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS;

EID: 84992655511     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00518-16     Document Type: Article

References (29)

1. Zumla A, George A, Sharma V, Herbert RH, Baroness Masham of Ilton, Oxley IA, Oliver M. 2015. The WHO 2014 global tuberculosis report - further to go. Lancet Glob Health 3:e10-e12. http://dx.doi.org/10.1016/S2214-109X(14)70361-4.
2. Wayne LG, Sohaskey CD. 2001. Non-replicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol 55:139-163. http://dx.doi.org/10.1146/annurev.micro.55.1.139.
3. Barry CE, III, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, Schnappinger D, Wilkinson RJ, Young D. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7:845-855. http://dx.doi.org/10.1038/nrmicro2236.
4. Kaprelyants AS, Gottschal JC, Kell DB. 1993. Dormancy in non-sporulating bacteria. FEMS Microbiol Rev 10:271-285.
5. Chao MC, Rubin EJ. 2010. Letting sleeping dos lie: does dormancy play a role in tuberculosis? Annu Rev Microbiol 64:293-311. http://dx.doi.org/10.1146/annurev.micro.112408.134043.
6. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43:717-731. http://dx.doi.org/10.1046/j.1365-2958.2002.02779.x.
7. Deb C, Lee CM, Dubey VS, Daniel J, Abomoelak B, Sirakova TD, Pawar S, Rogers L, Kolattukudy PE. 2009. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One 4:e6077. http://dx.doi.org/10.1371/journal.pone.0006077.
8. Sala C, Dhar N, Hartkoorn RC, Zhang M, Ha YH, Schneider P, Cole ST. 2010. Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 54:4150-4158. http://dx.doi.org/10.1128/AAC.00821-10.
9. Salina E, Ryabova O, Kaprelyants A, Makarov V. 2014. New 2-thiopyridines as potential candidates for killing both actively growing and dormant Mycobacterium tuberculosis cells. Antimicrob Agents Chemother 58:55-60. http://dx.doi.org/10.1128/AAC.01308-13.
10. Franzblau SG, DeGroote MA, Cho SH, Andries K, Nuermberger E, Orme IM, Mdluli K, Angulo-Barturen I, Dick T, Dartois V, Lenaerts AJ. 2012. Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis. Tuberculosis (Edinb) 92:453-488. http://dx.doi.org/10.1016/j.tube.2012.07.003.
11. Turapov O, Glenn S, Kana B, Makarov V, Andrew PW, Mukamolova GV. 2014. The in vivo environment accelerates generation of resuscitation-promoting factor-dependent mycobacteria. Am J Respir Crit Care Med 190:1455-1457. http://dx.doi.org/10.1164/rccm.201407-1289LE.
12. Manina G, Dhar N, McKinney JD. 2015. Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms. Cell Host Microbe 17:32-46. http://dx.doi.org/10.1016/j.chom.2014.11.016.
13. Mukamolova GV, Turapov OA, Young DI, Kaprelyants AS, Kell DB, Young M. 2002. A family of autocrine growth factors in Mycobacterium tuberculosis. Mol Microbiol 46:623-635. http://dx.doi.org/10.1046/j.1365-2958.2002.03184.x.
14. Shleeva MO, Bagramyan K, Telkov MV, Mukamolova GV, Young M, Kell DB, Kaprelyants AS. 2002. Formation and resuscitation of "non-culturable" cells of Rhodococcus rhodochrous and Mycobacterium tuberculosis in prolonged stationary phase. Microbiology 148:1581-1591. http://dx.doi.org/10.1099/00221287-148-5-1581.
15. Shleeva M, Mukamolova GV, Young M, Williams HD, Kaprelyants AS. 2004. Formation of 'non-culturable' cells of Mycobacterium smegmatis in stationary phase in response to growth under suboptimal conditions and their Rpf-mediated resuscitation. Microbiology 150:1687-1697. http://dx.doi.org/10.1099/mic.0.26893-0.
16. Mukamolova GV, Turapov O, Malkin J, Woltmann G, Barer MR. 2010. Resuscitation-promoting factors reveal an occult population of tubercle bacilli in sputum. Am J Respir Crit Care Med 181:174-180. http://dx.doi.org/10.1164/rccm.200905-0661OC.
17. Turapov O, O'Connor BD, Sarybaeva AA, Williams C, Patel H, Kadyrov AS, Sarybaev AS, Woltmann G, Barer MR, Mukamolova GV. 16 February 2016. Phenotypically adapted Mycobacterium tuberculosis populations from sputum are tolerant to first-line drugs. Antimicrob Agents Chemother http://dx.doi.org/10.1128/AAC.01380-15.
18. Hu Y, Liu A, Ortega-Muro F, Alameda-Martin L, Mitchison D, Coates A. 2015. High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo. Front Microbiol 6:641. http://dx.doi.org/10.3389/fmicb.2015.00641.
19. Mukamolova GV, Murzin AG, Salina EG, Demina GR, Kell DB, Kaprelyants AS, Young M. 2006. Muralytic activity of Micrococcus luteus Rpf and its relationship to physiological activity in promoting bacterial growth and resuscitation. Mol Microbiol 59:84-98. http://dx.doi.org/10.1111/j.1365-2958.2005.04930.x.
20. Kaprelyants AS, Mukamolova GV, Ruggiero A, Makarov VA, Demina GR, Shleeva MO, Potapov VD, Shramko PA. 2012. Resuscitation-promoting factors (Rpf): in search of inhibitors. Protein Pept Lett 19:1026-1034. http://dx.doi.org/10.2174/092986612802762723.
21. O'Connor BD, Woltmann G, Patel H, Turapov O, Haldar P, Mukamolova GV. 2015. Can resuscitation-promoting factors be used to improve culture rates of extra-pulmonary tuberculosis? Int J Tuberc Lung Dis 19:1556-1557. http://dx.doi.org/10.5588/ijtld.15.0682.
22. Mukamolova GV, Turapov OA, Kazarian K, Telkov M, Kaprelyants AS, Kell DB, Young M. 2002. The rpf gene of Micrococcus luteus encodes an essential secreted growth factor. Mol Microbiol 46:611-621. http://dx.doi.org/10.1046/j.1365-2958.2002.03183.x.
23. Turapov O, Loraine J, Jenkins CH, Barthe P, McFeely D, Forti F, Ghisotti D, Hesek D, Lee M, Bottrill AR, Vollmer W, Mobashery S, Cohen-Gonsaud M, Mukamolova GV. 2015. The external PASTA domain of the essential serine/threonine protein kinase PknB regulates mycobacterial growth. Open Biol 5:150025. http://dx.doi.org/10.1098/rsob.150025.
24. Blokpoel MC, Murphy HN, O'Toole R, Wiles S, Runn ES, Stewart GR, Young DB, Robertson BD. 2005. Tetracycline-inducible gene regulation in mycobacteria. Nucleic Acids Res 33:e22. http://dx.doi.org/10.1093/nar/gni023.
25. Waddell SJ, Butcher PD. 2010. Use of DNA arrays to study transcriptional responses to antimycobacterial compounds. Methods Mol Biol 642:75-91. http://dx.doi.org/10.1007/978-1-60327-279-7-6.
26. Turapov O, Waddell SJ, Burke B, Glenn S, Sarybaeva AA, Tudo G, Labesse G, Young DI, Young M, Andrew PW, Butcher PD, Cohen-Gonsaud M, Mukamolova GV. 2014. Antimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions. Antimicrob Agents Chemother 58:2798-2806. http://dx.doi.org/10.1128/AAC.02774-13.
27. Hett EC, Chao MC, Deng LL, Rubin EJ. 2008. A mycobacterial enzyme essential for cell division synergizes with resuscitation-promoting factor. PLoS Pathog 4:e1000001. http://dx.doi.org/10.1371/journal.ppat.1000001.
28. Kolwijck E, Friedrich SO, Karinja MN, van Ingen J, Warren RM, Diacon AH. 2014. Early stationary phase culture supernatant accelerates growth of sputum cultures collected after initiation of anti-tuberculosis treatment. Clin Microbiol Infect 20:O418-O420. http://dx.doi.org/10.1111/1469-0691.12441.
29. Lewis K. 2010. Persister cells. Annu Rev Microbiol 64:357-372. http://dx.doi.org/10.1146/annurev.micro.112408.134306.